![]()
Phenotype Annotations Click to see Annotation Detail View
Mammalian PhenotypeTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | abnormal gait | | IMP | | 13210569 | | RGD | | abnormal motor coordination/balance | | IMP | | 13210569 | | RGD | | abnormal muscle tone | | IMP | | 13210569 | | RGD | | decreased brain tyrosine 3-monooxygenase activity | | IMP | | 13210569 | | RGD | | decreased grip strength | | IMP | | 13210569 | | RGD | | decreased locomotor activity | | IMP | | 13210569 | | RGD | | decreased substantia nigra cell number | | IMP | | 11560775 | compared to LEH | RGD | | decreased substantia nigra size | | IMP | | 11560775 | compared to LEH | RGD | | decreased vertical activity | | IMP | | 13210569 | | RGD | | increased body weight | | IMP | | 13210569 | | RGD | | increased dopamine level | | IMP | | 13210569 | | RGD | | increased oxygen consumption | onset | IMP | | 11560775 | compared to LEH | RGD | | increased serotonin level | | IMP | | 13210569 | | RGD | | loss of dopaminergic neurons | | IMP | | 13210569 | | RGD | | |